Park Seungil Named Asan Medical Center President; Professor Lee Jehwan Named Seoul Asan Medical Center President

Asan Foundation Appointments

Park Seungil, president of Seoul Asan Medical Center, has been appointed president of Asan Medical Center, while Lee Jehwan, vice president of medical affairs at Seoul Asan Medical Center, has been appointed president of Seoul Asan Medical Center.


Park Seungil, Director of Asan Medical Center (left); Lee Jehwan, Director of Seoul Asan Hospital.

Park Seungil, Director of Asan Medical Center (left); Lee Jehwan, Director of Seoul Asan Hospital.

View original image

The Asan Foundation announced on Nov. 20 that the appointments will take effect on Jan. 1, 2027.


Before his appointment, Park served as head of the Medical Support Office, head of the Planning and Coordination Office, and vice president of medical affairs at Seoul Asan Medical Center. He led the hospital as its president from 2021 through 2026. He has worked to strengthen the hospital's future competitiveness, including by 추진ing the construction of a heavy-ion therapy center to offer new treatment opportunities to patients with intractable cancers. A professor of thoracic and cardiovascular surgery, he is a leading authority in lung cancer surgery and lung transplantation. In 2017, he performed Korea's first successful living-donor lung transplant.



Before his appointment, Lee served as head of the Department of Internal Medicine and head of the Medical Support Office at Seoul Asan Medical Center, then as vice president of medical affairs from 2021 through 2026, working to advance the hospital's medical services. Despite challenging circumstances, including the COVID-19 pandemic and conflicts between the medical community and the government, he established a stable care system focused on serious illnesses. He is also working to advance value-based healthcare, which seeks to improve patients' quality of life alongside treating their illnesses. As a professor of hematology, he has devoted himself to the diagnosis, treatment, and research of blood cancers. In recognition of his contributions, he received the Order of Service Merit, Okjo Medal, in March 2026.